Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The current management of Type 2 Diabetes Mellitus (T2DM) includes incretin-based treatments
The approved incretin‑based therapies fall into two main drug classes: Glucagon like peptide 1 (GLP-1) receptor agonists and CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors
see also:
CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors & Type 2 Diabetes (T2D)
Fatty Acids & Incretins
[Glucagon like peptide 1 (GLP-1) re…